Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
November 8, 2018
Cabaletta Bio Emerges Out of University of Pennsylvania to Develop CAAR T Cell Technology to Treat B Cell-mediated Autoimmune Diseases
November 8, 2018
Homology Medicines Presents Data on Platform’s Ability to Target the Central and Peripheral Nervous System and Therapeutic Potential in the Rare Disease Metachromatic Leukodystrophy
November 7, 2018
Flexion Therapeutics Reports Third-Quarter 2018 Financial Results and Recent Business Highlights
November 6, 2018
Audentes Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
November 5, 2018
Audentes Therapeutics Board of Directors Appoints Co-Founder and Chief Executive Officer Matthew R. Patterson as Chairman
November 5, 2018
Nouscom Strengthens Board Of Directors With The Appointment Of John F. McDonald As An Independent Director
October 24, 2018
IDEAYA Licenses Phase 1 Compound LXS196 For The Treatment Of Cancers With GNAQ And GNA11 Mutations
October 4, 2018
Cidara Therapeutics Presents Results From Successful Phase 2 STRIVE Trial Evaluating Rezafungin at IDWeek 2018
October 3, 2018
Audentes Therapeutics Announces Co-Founder and Chief Executive Officer Matthew R. Patterson Appointed Chairman of the Alliance for Regenerative Medicine
October 2, 2018
Scientist.com Partners with BIO® to Deliver Time and Cost Savings to Members
« Previous Page
1
…
57
58
59
60
61
…
103